Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study

International Journal of Cardiology

Volumn 143, Issue 3, 2010, Pages 399-404

  Rana, Jamal S ^a,b   Visser, Maartje E ^b   Arsenault, Benoit J ^c   Després, Jean Pierre ^c   Stroes, Erik S G ^b   Kastelein, John J P ^b   Wareham, Nicholas J ^d   Boekholdt, S Matthijs ^b   Khaw, Kay Tee ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c LAVAL UNIVERSITY   (Canada)

^d MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Coronary heart disease; High density lipoprotein cholesterol; Metabolic syndrome; Residual risk; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ASYMPTOMATIC DISEASES; CHOLESTEROL, HDL; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; GREAT BRITAIN; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES;

EID: 77955652957     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.03.123     Document Type: Article

References (20)

1. R.W. Nesto Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome Am J Cardiovasc Drugs 5 6 2005 379 387
2. J.D. Brunzell, M. Davidson, and C.D. Furberg Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation J Am Coll Cardiol 51 15 2008 1512 1524
3. B.J. Arsenault, I. Lemieux, and J.P. Despres Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population study Eur Heart J 28 22 2007 2770 2777
4. C.D. Gardner, S.P. Fortmann, and R.M. Krauss Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women JAMA 276 11 1996 875 881
5. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment III) final report. 106, 3143-3421. 2002. Ref Type: Generic
6. B.G. Brown, K.H. Stukovsky, and X.Q. Zhao Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials Curr Opin Lipidol 17 6 2006 631 636
7. N. Sarwar, J. Danesh, and G. Eiriksdottir Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies Circulation 115 4 2007 450 458
8. N. Day, S. Oakes, R. Luben, K.T. Khaw, S. Bingham, and A. Welch EPIC-Norfolk: study design and characteristics of the cohort Br J Cancer 80 suppl 1 1999 95 103
9. S.M. Boekholdt, R.J. Peters, and N.E. Day Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study Am J Med 117 6 2004 390 397
10. N.J. Wareham, R.W. Jakes, and K.L. Rennie Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study Public Health Nutr 6 4 2003 407 413
11. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 6 1972 499 502
12. K.T. Khaw, N. Wareham, S. Bingham, R. Luben, A. Welch, and N. Day Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk Ann Intern Med 141 6 2004 413 420
13. M. Arca, A. Montali, and S. Valiante Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease Am J Cardiol 100 10 2007 1511 1516
14. C.M. Ballantyne, A.G. Olsson, T.J. Cook, M.F. Mercuri, T.R. Pedersen, and J. Kjekshus Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S Circulation 104 25 2001 3046 3051
15. A.S. Gami, B.J. Witt, and D.E. Howard Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies J Am Coll Cardiol 49 4 2007 403 414
16. A. Tirosh, A. Rudich, and T. Shochat Changes in triglyceride levels and risk for coronary heart disease in young men Ann Intern Med 147 6 2007 377 385
17. S. Bansal, J.E. Buring, N. Rifai, S. Mora, F.M. Sacks, and P.M. Ridker Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women JAMA 298 3 2007 309 316
18. B.G. Nordestgaard, M. Benn, P. Schnohr, and A. Tybjaerg-Hansen Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women JAMA 298 3 2007 299 308
19. J.C. Fruchart, F. Sacks, and M.P. Hermans The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia Am J Cardiol 102 10 Suppl 2008 1K 34K
20. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150